特发性肺纤维化：历史回顾
Idiopathic pulmonary fibrosis: a historical review.
作者信息
Homolka J
机构信息
1st Lung Department, Faculty of Medicine, Charles University, Prague, Czechoslovakia.
出版信息
CMAJ. 1987 Dec 1;137(11):1003-5.
Abstract
Hamman and Rich are generally considered to have been the first to describe idiopathic pulmonary fibrosis (IPF) as a new clinical and pathological entity. However, several earlier reports in the German-language literature described autopsy findings consistent with IPF from a contemporary point of view. The author discusses these and later reports in a review of the history, diagnosis and treatment of the disease.
摘要
哈曼和里奇通常被认为是最早将特发性肺纤维化（IPF）描述为一种新的临床和病理实体的人。然而，德语文献中的一些早期报告从当代角度描述了与IPF一致的尸检结果。作者在对该疾病的历史、诊断和治疗的综述中讨论了这些以及后来的报告。
相似文献
1
Idiopathic pulmonary fibrosis: a historical review.特发性肺纤维化：历史回顾
CMAJ. 1987 Dec 1;137(11):1003-5.
2
Idiopathic pulmonary fibrosis: the disease in search of its cause.
Curr Opin Pulm Med. 2006 Sep;12(5):310-1. doi: 10.1097/01.mcp.0000239545.17208.15.
3
[A documented case of typical Hamman-Rich interstitial pulmonary fibrosis].[一例典型的Hamman-Rich间质性肺纤维化的文献报道病例]
Minerva Med. 1981 Jun 23;72(25):1599-603.
4
[Idiopathic pulmonary fibrosis].[特发性肺纤维化]
Vnitr Lek. 2005 Dec;51(12):1375-84.
5
Back to the future: historical perspective on the pathogenesis of idiopathic pulmonary fibrosis.回到未来：特发性肺纤维化发病机制的历史视角
Am J Respir Cell Mol Biol. 2005 Aug;33(2):113-20. doi: 10.1165/rcmb.F301.
6
Spectrum and diagnosis of idiopathic pulmonary fibrosis.特发性肺纤维化的谱系与诊断
Indian J Chest Dis Allied Sci. 2004 Jan-Mar;46(1):23-6.
7
Surfactant protein-A in lung lavage fluid obtained from patients with idiopathic pulmonary fibrosis.从特发性肺纤维化患者获得的肺灌洗液中的表面活性蛋白A。
J Assoc Physicians India. 2002 Nov;50:1409-12.
8
Idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis.特发性肺纤维化/隐源性纤维性肺泡炎
Clin Exp Med. 2003 Sep;3(2):65-83. doi: 10.1007/s10238-003-0010-3.
9
[Idiopathic interstitial pneumonia (IIP), idiopathic pulmonary fibrosis (IPF), and Hamman-Rich syndrome].[特发性间质性肺炎（IIP）、特发性肺纤维化（IPF）和Hamman-Rich综合征]
Ryoikibetsu Shokogun Shirizu. 1994(3):598-601.
10
[The Hamman-Rich syndrome: actuality and limitations. Considerations on a case of "idiopathic" diffuse pulmonary fibrosis].[哈曼-里奇综合征：现状与局限性。关于一例“特发性”弥漫性肺纤维化病例的思考]
Pathologica. 1982 Mar-Apr;74(1030):173-81.
引用本文的文献
1
Optimizing patient outcomes in interstitial lung disease through pre- and post-transplant management strategies.通过移植前和移植后管理策略优化间质性肺疾病患者的治疗效果。
World J Transplant. 2025 Sep 18;15(3):101866. doi: 10.5500/wjt.v15.i3.101866.
2
Inhaled siRNA nanoparticles targeting inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge.吸入型靶向 siRNA 纳米颗粒抑制博来霉素所致肺纤维化并改善肺功能。
Sci Adv. 2022 Jun 24;8(25):eabn7162. doi: 10.1126/sciadv.abn7162. Epub 2022 Jun 22.
3
Morphological and molecular motifs of fibrosing pulmonary injury patterns.纤维化性肺损伤模式的形态学和分子特征。
J Pathol Clin Res. 2019 Oct;5(4):256-271. doi: 10.1002/cjp2.141. Epub 2019 Sep 25.
4
Imaging in idiopathic pulmonary fibrosis: diagnosis and mimics.特发性肺纤维化的影像学表现：诊断与鉴别诊断。
Clinics (Sao Paulo). 2019 Feb 4;74:e225. doi: 10.6061/clinics/2019/e225.
5
[Injury patterns in interstitial lung diseases].[间质性肺疾病中的损伤模式]
Pathologe. 2018 Dec;39(Suppl 2):262-271. doi: 10.1007/s00292-018-0503-1.
6
Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis.脂肪生成性与肌源性成纤维细胞表型之间的双向转化标志着肺纤维化的进展与消退。
Cell Stem Cell. 2017 Feb 2;20(2):261-273.e3. doi: 10.1016/j.stem.2016.10.004. Epub 2016 Nov 17.
7
Diagnostic approach to interstitial pneumonias in a single centre: report on 88 cases.单一中心间质性肺炎的诊断方法：88 例报告。
Diagn Pathol. 2012 Nov 26;7:160. doi: 10.1186/1746-1596-7-160.
本文引用的文献
1
[Evolving interstitial pneumofibrosis a new entity?].[不断演变的间质性肺纤维化——一种新的疾病实体？]
Hoja Tisiol. 1949 Sep;9(3):207-21.
2
Diffuse fibrosing interstitial pneumonitis (interstitial fibrosis of the lungs).弥漫性纤维化间质性肺炎（肺间质纤维化）
Am J Clin Pathol. 1952 Aug;22(8):770-6. doi: 10.1093/ajcp/22.8.770.
3
Diffuse interstitial fibrosis of the lungs.肺部弥漫性间质纤维化
Ann Intern Med. 1952 Mar;36(3):827-44. doi: 10.7326/0003-4819-36-3-827.
4
Clinical and physiologic features of some types of pulmonary diseases with impairment of alveolar-capillary diffusion; the syndrome of "alveolar-capillary block".某些伴有肺泡-毛细血管弥散功能障碍的肺部疾病的临床和生理特征；“肺泡-毛细血管阻滞”综合征
Am J Med. 1951 Dec;11(6):667-85. doi: 10.1016/0002-9343(51)90019-8.
5
Chronic diffuse interstitial fibrosis of the lungs.慢性弥漫性肺间质纤维化
Thorax. 1951 Dec;6(4):426-32. doi: 10.1136/thx.6.4.426.
6
Familial pulmonary fibrosis.家族性肺纤维化
Dis Chest. 1951 Oct;20(4):426-36. doi: 10.1378/chest.20.4.426.
7
Idiopathic pulmonary fibrosis; its occurrence in identical twin sisters.特发性肺纤维化；其在同卵双胞胎姐妹中的发生情况。
Dis Chest. 1950 Oct;18(4):330-44. doi: 10.1016/s0096-0217(15)34710-5.
8
Chronic diffuse interstitial fibrosis of the lungs.慢性弥漫性肺间质纤维化
Br Med J. 1960 Feb 13;1(5171):443-50. doi: 10.1136/bmj.1.5171.443.
9
[Interstitial, nonpurulent pneumonia; diffuse pulmonary fibrosis and pulmonary cirrhosis].[间质性非化脓性肺炎；弥漫性肺纤维化和肺硬变]
Zentralbl Allg Pathol. 1954 Nov 20;92(10-11):405-16.
10
FIBROSING ALVEOLITIS.纤维化肺泡炎
Br Med J. 1964 Sep 12;2(5410):686. doi: 10.1136/bmj.2.5410.686.
Zotero 插件